Hurley Capital, LLC Neuro Sense Therapeutics Ltd. Transaction History
Hurley Capital, LLC
- $132 Billion
- Q1 2025
A detailed history of Hurley Capital, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Hurley Capital, LLC holds 8,710 shares of NRSN stock, worth $13,239. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,710Holding current value
$13,239% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
12Shares Held
195KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY50.5KShares$76,7610.0% of portfolio
-
Meitav Dash Investments LTD40KShares$60,8000.0% of portfolio
-
Xtx Topco LTD London, X033.7KShares$51,2330.0% of portfolio
-
Commonwealth Equity Services, LLC17.3KShares$26,2200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.9KShares$24,1220.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $17.7M